Article

Low-dose cyclosporine mediates donor hyporesponsiveness in a fully mismatched rat kidney transplant model

Department of Visceral, Transplantation and Thoracic Surgery, Medizinische Universitaet Innsbruck, Austria
Transplant Immunology (Impact Factor: 1.83). 03/2012; 26(4):176-85. DOI: 10.1016/j.trim.2012.02.004
Source: PubMed

ABSTRACT Tolerance induction protocols have been successfully tested in animal models, yet their compatibility with immunosuppressive drugs remains to be fully elucidated. Our own previous data have indicated that cyclosporine A (CsA) affects the balance of effector and regulatory mechanisms with low-dose CsA doses promoting hyporesponsiveness. Here, we present a fully mismatched rat kidney model in which low-dose CsA treatment induces donor hyporesponsiveness to secondary renal allografts. Lewis recipients of DA kidney grafts received low, medium or high doses of CsA × 10 days. By 30 days, the primary transplant was removed and a second transplant of donor origin was engrafted. Following low-dose CsA, but not high-dose CsA treatment of the primary recipient, secondary transplants were accepted long-term in the absence of immunosuppression. Regulatory T-cell function was unimpaired and independent of the CyA dosage. Of note, low-dose CsA significantly reduced alloantibody titers in primary recipients. Adoptive transfer of graft infiltrating cells or splenocytes from hyporesponsive recipients supported long-term acceptance of donor kidney allografts. These results demonstrate a dose-dependent and transferable "pro-tolerogenic" effect of low-dose CsA treatment. This model is of clinical relevance to test the interference of CsA with tolerance induction in the absence of additional immunosuppression.

Download full-text

Full-text

Available from: Anja Reutzel-Selke, Dec 17, 2013
0 Followers
 · 
143 Views
 · 
81 Downloads
  • Source
    • "Albumin levels in urine were measured as a sign of injury and were significantly increased four weeks after Tx, but no difference was observed between DA.Ncf1 DA/DA and DA.Ncf1 E3/E3 recipients (Fig. 1D). It should be noted that the albuminuria in this model is low compared to other strain combinations, where 8–10 mg/24 h have been measured [17] [18]. In addition, damage to the kidney four weeks after Tx was confirmed by strong expression of the tubular the injury marker KIM-1, but again no difference was observed between DA.Ncf1 DA/DA and DA.Ncf1 E3/E3 recipients (Fig. 1E, F). "
    [Show abstract] [Hide abstract]
    ABSTRACT: We previously showed that anti-inflammatory Mph (Mph2) can both in vitro and in vivo induce regulatory T cells (Tregs) in a reactive oxygen species (ROS)-dependent fashion. As influx of Mph is an important characteristic of chronic inflammatory responses, we investigated the impact of NOX2-mediated ROS production by recipient cells in an experimental model of chronic allograft inflammation. We used a kidney transplantation (Tx) model with Lewis (Lew) rats as donor and congenic DA.Ncf1(DA/DA) (low ROS) and DA.Ncf1(E3/E3) (normal ROS) rats as recipients. At day 7 the contralateral kidney was removed, and the animals were sacrificed four weeks after Tx. Renal function and injury was monitored in serum and urine and the composition of the infiltrate was analyzed by immunohistochemistry. Four weeks after Tx, large leukocyte clusters were observed in the allograft, in which signs of ROS production could be demonstrated. These clusters showed no difference regarding composition of myeloid cells or the number of FoxP3 positive cells. However, T cell infiltrate was significantly reduced in the DA.Ncf1(E3/E3) recipients having normal ROS production. Therefore, this study suggests a regulatory effect of ROS on T cell infiltration, but no effect on other inflammatory cells in the allograft.
    Transplant Immunology 12/2013; DOI:10.1016/j.trim.2013.12.001 · 1.83 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The precise roles of mast cells in liver allograft rejection and tolerance are still unknown. This study aimed to explore the roles of mast cells in immune regulation and liver regeneration for tolerance induction by using rat models of orthotopic liver transplantation (OLT). Stem cell factor (SCF) and its receptor c-Kit, which are critical to the migration and development of not only stem cells but also mast cells, significantly increased in the tolerogenic livers as compared with rejected livers. The significant elevation of mast cell tryptase, high-affinity IgE receptor, and histamine suggested the activation of mast cells in liver allografts at the tolerogenic phase after OLT. Immunohistochemical analysis using confocal microscope clearly showed colocalization of mast cells, Foxp3+ Tregs, γδ T cells, and recipient-derived hepatic progenitor cells with higher expression of SCF, IL-9, IL-10, TGF-β1, and IL-17 related to immunoregulation and liver regeneration in the donor grafts of a tolerogenic OLT model. Cross-talk among mast cells and other cells was evaluated by in vitro studies demonstrating that syngeneic bone marrow-derived mast cells (BMMCs) co-cultured with naïve splenocytes or primary hepatocytes significantly increased the population of splenic γδ T cells by mitogen stimulation or by mast cell degranulation, and also significantly induced the hepatocyte proliferation, respectively. Our results suggested that mast cells in the donor grafts may play important roles in the induction/maintenance of immune tolerance and liver regeneration resulting in the replacement of hepatic cells from donor to recipient.
    PLoS ONE 05/2012; 7(5):e37202. DOI:10.1371/journal.pone.0037202 · 3.23 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Chronic allograft nephropathy is the leading cause of late allograft loss after renal transplantation (RT), which continues to remain an unresolved problem. A rat model of chronic allograft nephropathy (CAN) was first described in 1969 by White et al. Although the rat model of RT can be technically challenging, it is attractive for several reasons because the pathogenesis of CAN is similar to that following human RT and the pathological features of CAN develop within months as compared to years in human RT. The rat model of RT is considered as a useful investigational tool in the field of experimental transplantation research. We have reviewed the literature on studies of rat RT reporting the donor and recipient strain combinations that have investigated resultant survival and histological outcomes. Several different combinations of inbred and outbred rat combinations have been reported to investigate the multiple aspects of transplantation including acute rejection, cellular and humoral rejection mechanisms and their treatments, CAN and potential targets for its prevention.
    International Journal of Nephrology and Renovascular Disease 05/2014; 7:315-322. DOI:10.2147/IJNRD.S65604